« Back
Home /
RBN013209

RBN013209

Item no.	MOLN-M28545-200mg
Manufacturer	Molnova
CASRN	2597933-17-8
Amount	200 mg
Quantity options	100 mg 10 mg 1 g 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category	Reagents & Chemicals Other Chemicals
Type	Chemicals
Specific against	other
Purity	>98% (HPLC)
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Available
Molecular Weight	384, 43
Brief description	RBN013209 is a potent CD38 inhibitor. RBN013209 is useful in the treatment of cancer.
Note	Research use only, not for human use.
Stability	≥ 2 years
Receptor	cPLA2α\|Human Endogenous Metabolite

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 200 mg

available

Delivery expected until 6/19/2025

Express Delivery: Save 6 days

Compare

Add to wishlist

Recommend by mail